| Squamous Cell Carcinoma altered in cohorts of …ALTERED_INderived200 of 474show all (up to 200) |
|---|
| ← altered in cohorts of | MUC12 24 / 25 cases (96 %) · ssm · cscc_ranson_2022 | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ABCC5 444 / 504 cases (88 %) · ssm · TCGA-LUSC | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CCDC39 444 / 504 cases (88 %) · ssm · TCGA-LUSC | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | DVL3 444 / 504 cases (88 %) · ssm · TCGA-LUSC | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | EEF1AKMT4-ECE2 444 / 504 cases (88 %) · ssm · TCGA-LUSC | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | EPHB3 444 / 504 cases (88 %) · ssm · TCGA-LUSC | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | KLHL6 444 / 504 cases (88 %) · ssm · TCGA-LUSC | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | WDFY4 22 / 25 cases (88 %) · ssm · cscc_ranson_2022 | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ABCF3 443 / 504 cases (88 %) · ssm · TCGA-LUSC | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ACTRT3 443 / 504 cases (88 %) · ssm · TCGA-LUSC | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CHRD 443 / 504 cases (88 %) · ssm · TCGA-LUSC | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CLCN2 443 / 504 cases (88 %) · ssm · TCGA-LUSC | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | DCUN1D1 443 / 504 cases (88 %) · ssm · TCGA-LUSC | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | EIF2B5 443 / 504 cases (88 %) · ssm · TCGA-LUSC | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | HTR3C 443 / 504 cases (88 %) · ssm · TCGA-LUSC | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | HTR3E 443 / 504 cases (88 %) · ssm · TCGA-LUSC | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | MAGEF1 443 / 504 cases (88 %) · ssm · TCGA-LUSC | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | MAP6D1 443 / 504 cases (88 %) · ssm · TCGA-LUSC | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PARL 443 / 504 cases (88 %) · ssm · TCGA-LUSC | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SOX2 443 / 504 cases (88 %) · ssm · TCGA-LUSC | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | VPS8 443 / 504 cases (88 %) · ssm · TCGA-LUSC | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ZBBX 443 / 504 cases (88 %) · ssm · TCGA-LUSC · largest of 3 cohorts | — | — | Lung Squamous Cell Carcinoma | 3 | Observed | gdc | graph → |
| ← altered in cohorts of | AP2M1 442 / 504 cases (88 %) · ssm · TCGA-LUSC | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | C3orf70 442 / 504 cases (88 %) · ssm · TCGA-LUSC | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | FAM131A 442 / 504 cases (88 %) · ssm · TCGA-LUSC | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | KLHL24 442 / 504 cases (88 %) · ssm · TCGA-LUSC | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | LAMP3 442 / 504 cases (88 %) · ssm · TCGA-LUSC | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | MCCC1 442 / 504 cases (88 %) · ssm · TCGA-LUSC | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PHC3 442 / 504 cases (88 %) · ssm · TCGA-LUSC | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SAMD7 442 / 504 cases (88 %) · ssm · TCGA-LUSC | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | THPO 442 / 504 cases (88 %) · ssm · TCGA-LUSC | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | USP13 442 / 504 cases (88 %) · ssm · TCGA-LUSC | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | WDR49 442 / 504 cases (88 %) · ssm · TCGA-LUSC | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ALG3 441 / 504 cases (88 %) · ssm · TCGA-LUSC | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ATP13A5 441 / 504 cases (88 %) · ssm · TCGA-LUSC | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | B3GNT5 441 / 504 cases (88 %) · ssm · TCGA-LUSC | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CAMK2N2 441 / 504 cases (88 %) · ssm · TCGA-LUSC | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CLDN11 441 / 504 cases (88 %) · ssm · TCGA-LUSC | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | DNAJC19 441 / 504 cases (88 %) · ssm · TCGA-LUSC | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ECE2 441 / 504 cases (88 %) · ssm · TCGA-LUSC | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ECT2 441 / 504 cases (88 %) · ssm · TCGA-LUSC | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | EEF1AKMT4 441 / 504 cases (88 %) · ssm · TCGA-LUSC | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | HTR3D 441 / 504 cases (88 %) · ssm · TCGA-LUSC | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | KCNMB2 441 / 504 cases (88 %) · ssm · TCGA-LUSC | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | LRRC31 441 / 504 cases (88 %) · ssm · TCGA-LUSC | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | MASP1 441 / 504 cases (88 %) · ssm · TCGA-LUSC | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | POLR2H 441 / 504 cases (88 %) · ssm · TCGA-LUSC | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PRKCI 441 / 504 cases (88 %) · ssm · TCGA-LUSC | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PSMD2 441 / 504 cases (88 %) · ssm · TCGA-LUSC | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SLC2A2 441 / 504 cases (88 %) · ssm · TCGA-LUSC | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | VWA5B2 441 / 504 cases (88 %) · ssm · TCGA-LUSC | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | EIF5A2 440 / 504 cases (87 %) · ssm · TCGA-LUSC | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | GPR160 440 / 504 cases (87 %) · ssm · TCGA-LUSC | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | LRRC34 440 / 504 cases (87 %) · ssm · TCGA-LUSC | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | RPL22L1 440 / 504 cases (87 %) · ssm · TCGA-LUSC | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SEC62 440 / 504 cases (87 %) · ssm · TCGA-LUSC | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | EHHADH 439 / 504 cases (87 %) · ssm · TCGA-LUSC | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ETV5 439 / 504 cases (87 %) · ssm · TCGA-LUSC | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | IGF2BP2 439 / 504 cases (87 %) · ssm · TCGA-LUSC | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | MAP3K13 439 / 504 cases (87 %) · ssm · TCGA-LUSC | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PLAAT1 439 / 504 cases (87 %) · ssm · TCGA-LUSC | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SERPINI1 439 / 504 cases (87 %) · ssm · TCGA-LUSC | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | TMEM41A 439 / 504 cases (87 %) · ssm · TCGA-LUSC | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ZMAT3 439 / 504 cases (87 %) · ssm · TCGA-LUSC | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | LIPH 438 / 504 cases (87 %) · ssm · TCGA-LUSC | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | LRRC15 438 / 504 cases (87 %) · ssm · TCGA-LUSC | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | TBL1XR1 438 / 504 cases (87 %) · ssm · TCGA-LUSC | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | HMCN2 21 / 25 cases (84 %) · ssm · cscc_ranson_2022 | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | AKAP6 20 / 25 cases (80 %) · ssm · cscc_ranson_2022 | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | CDH23 20 / 25 cases (80 %) · ssm · cscc_ranson_2022 | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | MUC3A 20 / 25 cases (80 %) · ssm · cscc_ranson_2022 | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | MUC5AC 20 / 25 cases (80 %) · ssm · cscc_ranson_2022 | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | PPP1R3A 20 / 25 cases (80 %) · ssm · cscc_ranson_2022 | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | PTPRQ 20 / 25 cases (80 %) · ssm · cscc_ranson_2022 | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | SHANK1 20 / 25 cases (80 %) · ssm · cscc_ranson_2022 | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | TNRC18 20 / 25 cases (80 %) · ssm · cscc_ranson_2022 | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | TP53 392 / 528 cases (74 %) · ssm · TCGA-HNSC · largest of 22 cohorts | — | — | Head and Neck Squamous Cell Carcinoma | 22 | Observed | gdc | graph → |
| ← altered in cohorts of | PIK3CA 390 / 528 cases (74 %) · ssm · TCGA-HNSC · largest of 13 cohorts | — | — | Head and Neck Squamous Cell Carcinoma | 13 | Observed | gdc | graph → |
| ← altered in cohorts of | CSMD3 387 / 528 cases (73 %) · ssm · TCGA-HNSC · largest of 15 cohorts | — | — | Head and Neck Squamous Cell Carcinoma | 15 | Observed | gdc | graph → |
| ← altered in cohorts of | CDKN2A 384 / 528 cases (73 %) · ssm · TCGA-HNSC · largest of 11 cohorts | — | — | Head and Neck Squamous Cell Carcinoma | 11 | Observed | gdc | graph → |
| ← altered in cohorts of | FAM135B 383 / 528 cases (73 %) · ssm · TCGA-HNSC · largest of 13 cohorts | — | — | Head and Neck Squamous Cell Carcinoma | 13 | Observed | gdc | graph → |
| ← altered in cohorts of | PLD1 377 / 528 cases (71 %) · ssm · TCGA-HNSC · largest of 2 cohorts | — | — | Head and Neck Squamous Cell Carcinoma | 2 | Observed | gdc | graph → |
| ← altered in cohorts of | COL22A1 376 / 528 cases (71 %) · ssm · TCGA-HNSC · largest of 13 cohorts | — | — | Head and Neck Squamous Cell Carcinoma | 13 | Observed | gdc | graph → |
| ← altered in cohorts of | CLDN16 374 / 528 cases (71 %) · ssm · TCGA-HNSC | — | — | Head and Neck Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | BCL6 373 / 528 cases (71 %) · ssm · TCGA-HNSC | — | — | Head and Neck Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | IL1RAP 373 / 528 cases (71 %) · ssm · TCGA-HNSC | — | — | Head and Neck Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | MB21D2 373 / 528 cases (71 %) · ssm · TCGA-HNSC · largest of 2 cohorts | — | — | Head and Neck Squamous Cell Carcinoma | 2 | Observed | gdc | graph → |
| ← altered in cohorts of | PKHD1L1 373 / 528 cases (71 %) · ssm · TCGA-HNSC · largest of 12 cohorts | — | — | Head and Neck Squamous Cell Carcinoma | 12 | Observed | gdc | graph → |
| ← altered in cohorts of | SI 373 / 528 cases (71 %) · ssm · TCGA-HNSC · largest of 11 cohorts | — | — | Head and Neck Squamous Cell Carcinoma | 11 | Observed | gdc | graph → |
| ← altered in cohorts of | TP63 373 / 528 cases (71 %) · ssm · TCGA-HNSC · largest of 2 cohorts | — | — | Head and Neck Squamous Cell Carcinoma | 2 | Observed | gdc | graph → |
| ← altered in cohorts of | COL14A1 372 / 528 cases (70 %) · ssm · TCGA-HNSC · largest of 3 cohorts | — | — | Head and Neck Squamous Cell Carcinoma | 3 | Observed | gdc | graph → |
| ← altered in cohorts of | EIF4G1 372 / 528 cases (70 %) · ssm · TCGA-HNSC · largest of 2 cohorts | — | — | Head and Neck Squamous Cell Carcinoma | 2 | Observed | gdc | graph → |
| ← altered in cohorts of | MUC4 372 / 528 cases (70 %) · ssm · TCGA-HNSC · largest of 6 cohorts | — | — | Head and Neck Squamous Cell Carcinoma | 6 | Observed | gdc | graph → |
| ← altered in cohorts of | OSTN 372 / 528 cases (70 %) · ssm · TCGA-HNSC | — | — | Head and Neck Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | RUBCN 372 / 528 cases (70 %) · ssm · TCGA-HNSC | — | — | Head and Neck Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SPATA16 372 / 528 cases (70 %) · ssm · TCGA-HNSC · largest of 2 cohorts | — | — | Head and Neck Squamous Cell Carcinoma | 2 | Observed | gdc | graph → |
| ← altered in cohorts of | ADCY8 371 / 528 cases (70 %) · ssm · TCGA-HNSC · largest of 3 cohorts | — | — | Head and Neck Squamous Cell Carcinoma | 3 | Observed | gdc | graph → |
| ← altered in cohorts of | BDH1 371 / 528 cases (70 %) · ssm · TCGA-HNSC | — | — | Head and Neck Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CCDC50 371 / 528 cases (70 %) · ssm · TCGA-HNSC | — | — | Head and Neck Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | FER1L6 371 / 528 cases (70 %) · ssm · TCGA-HNSC | — | — | Head and Neck Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | FGF12 371 / 528 cases (70 %) · ssm · TCGA-HNSC · largest of 2 cohorts | — | — | Head and Neck Squamous Cell Carcinoma | 2 | Observed | gdc | graph → |
| ← altered in cohorts of | LPP 371 / 528 cases (70 %) · ssm · TCGA-HNSC | — | — | Head and Neck Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | MELTF 371 / 528 cases (70 %) · ssm · TCGA-HNSC | — | — | Head and Neck Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | NLGN1 371 / 528 cases (70 %) · ssm · TCGA-HNSC · largest of 2 cohorts | — | — | Head and Neck Squamous Cell Carcinoma | 2 | Observed | gdc | graph → |
| ← altered in cohorts of | PLEC 371 / 528 cases (70 %) · ssm · TCGA-HNSC · largest of 8 cohorts | — | — | Head and Neck Squamous Cell Carcinoma | 8 | Observed | gdc | graph → |
| ← altered in cohorts of | SLC7A14 371 / 528 cases (70 %) · ssm · TCGA-HNSC · largest of 2 cohorts | — | — | Head and Neck Squamous Cell Carcinoma | 2 | Observed | gdc | graph → |
| ← altered in cohorts of | SDHB 66 / 94 cases (70 %) · ssm · hnsc_a5consortium_2025 | — | — | Head and Neck Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | CLDN1 370 / 528 cases (70 %) · ssm · TCGA-HNSC · largest of 2 cohorts | — | — | Head and Neck Squamous Cell Carcinoma | 2 | Observed | gdc | graph → |
| ← altered in cohorts of | DLG1 370 / 528 cases (70 %) · ssm · TCGA-HNSC · largest of 2 cohorts | — | — | Head and Neck Squamous Cell Carcinoma | 2 | Observed | gdc | graph → |
| ← altered in cohorts of | GHSR 370 / 528 cases (70 %) · ssm · TCGA-HNSC · largest of 2 cohorts | — | — | Head and Neck Squamous Cell Carcinoma | 2 | Observed | gdc | graph → |
| ← altered in cohorts of | GMNC 370 / 528 cases (70 %) · ssm · TCGA-HNSC | — | — | Head and Neck Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | LSG1 370 / 528 cases (70 %) · ssm · TCGA-HNSC | — | — | Head and Neck Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | MYC 370 / 528 cases (70 %) · ssm · TCGA-HNSC | — | — | Head and Neck Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | NAALADL2 370 / 528 cases (70 %) · ssm · TCGA-HNSC · largest of 2 cohorts | — | — | Head and Neck Squamous Cell Carcinoma | 2 | Observed | gdc | graph → |
| ← altered in cohorts of | P3H2 370 / 528 cases (70 %) · ssm · TCGA-HNSC · largest of 2 cohorts | — | — | Head and Neck Squamous Cell Carcinoma | 2 | Observed | gdc | graph → |
| ← altered in cohorts of | PAK2 370 / 528 cases (70 %) · ssm · TCGA-HNSC | — | — | Head and Neck Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PCYT1A 370 / 528 cases (70 %) · ssm · TCGA-HNSC | — | — | Head and Neck Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PYDC2 370 / 528 cases (70 %) · ssm · TCGA-HNSC | — | — | Head and Neck Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | RTP2 370 / 528 cases (70 %) · ssm · TCGA-HNSC | — | — | Head and Neck Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | TG 370 / 528 cases (70 %) · ssm · TCGA-HNSC · largest of 4 cohorts | — | — | Head and Neck Squamous Cell Carcinoma | 4 | Observed | gdc | graph → |
| ← altered in cohorts of | TMEM207 370 / 528 cases (70 %) · ssm · TCGA-HNSC | — | — | Head and Neck Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | UTS2B 370 / 528 cases (70 %) · ssm · TCGA-HNSC | — | — | Head and Neck Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ACAP2 369 / 528 cases (70 %) · ssm · TCGA-HNSC | — | — | Head and Neck Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | APOD 369 / 528 cases (70 %) · ssm · TCGA-HNSC | — | — | Head and Neck Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ATP13A3 369 / 528 cases (70 %) · ssm · TCGA-HNSC | — | — | Head and Neck Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ATP13A4 369 / 528 cases (70 %) · ssm · TCGA-HNSC | — | — | Head and Neck Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CPN2 369 / 528 cases (70 %) · ssm · TCGA-HNSC | — | — | Head and Neck Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | FNDC3B 369 / 528 cases (70 %) · ssm · TCGA-HNSC · largest of 2 cohorts | — | — | Head and Neck Squamous Cell Carcinoma | 2 | Observed | gdc | graph → |
| ← altered in cohorts of | FXR1 369 / 528 cases (70 %) · ssm · TCGA-HNSC · largest of 2 cohorts | — | — | Head and Neck Squamous Cell Carcinoma | 2 | Observed | gdc | graph → |
| ← altered in cohorts of | IQCG 369 / 528 cases (70 %) · ssm · TCGA-HNSC | — | — | Head and Neck Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | KCNQ3 369 / 528 cases (70 %) · ssm · TCGA-HNSC | — | — | Head and Neck Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | LRCH3 369 / 528 cases (70 %) · ssm · TCGA-HNSC | — | — | Head and Neck Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | MFN1 369 / 528 cases (70 %) · ssm · TCGA-HNSC | — | — | Head and Neck Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | MUC20 369 / 528 cases (70 %) · ssm · TCGA-HNSC | — | — | Head and Neck Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | MYNN 369 / 528 cases (70 %) · ssm · TCGA-HNSC · largest of 2 cohorts | — | — | Head and Neck Squamous Cell Carcinoma | 2 | Observed | gdc | graph → |
| ← altered in cohorts of | NRROS 369 / 528 cases (70 %) · ssm · TCGA-HNSC | — | — | Head and Neck Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PEX5L 369 / 528 cases (70 %) · ssm · TCGA-HNSC · largest of 2 cohorts | — | — | Head and Neck Squamous Cell Carcinoma | 2 | Observed | gdc | graph → |
| ← altered in cohorts of | PHF20L1 369 / 528 cases (70 %) · ssm · TCGA-HNSC | — | — | Head and Neck Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PIGZ 369 / 528 cases (70 %) · ssm · TCGA-HNSC | — | — | Head and Neck Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PPP1R2 369 / 528 cases (70 %) · ssm · TCGA-HNSC | — | — | Head and Neck Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SENP5 369 / 528 cases (70 %) · ssm · TCGA-HNSC | — | — | Head and Neck Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SMCO1 369 / 528 cases (70 %) · ssm · TCGA-HNSC | — | — | Head and Neck Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | TFRC 369 / 528 cases (70 %) · ssm · TCGA-HNSC | — | — | Head and Neck Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | TNFSF10 369 / 528 cases (70 %) · ssm · TCGA-HNSC · largest of 2 cohorts | — | — | Head and Neck Squamous Cell Carcinoma | 2 | Observed | gdc | graph → |
| ← altered in cohorts of | TNIK 369 / 528 cases (70 %) · ssm · TCGA-HNSC · largest of 2 cohorts | — | — | Head and Neck Squamous Cell Carcinoma | 2 | Observed | gdc | graph → |
| ← altered in cohorts of | TNK2 369 / 528 cases (70 %) · ssm · TCGA-HNSC | — | — | Head and Neck Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | TPRG1 369 / 528 cases (70 %) · ssm · TCGA-HNSC | — | — | Head and Neck Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | UBXN7 369 / 528 cases (70 %) · ssm · TCGA-HNSC | — | — | Head and Neck Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | YEATS2 369 / 528 cases (70 %) · ssm · TCGA-HNSC · largest of 2 cohorts | — | — | Head and Neck Squamous Cell Carcinoma | 2 | Observed | gdc | graph → |
| ← altered in cohorts of | ACTL6A 368 / 528 cases (70 %) · ssm · TCGA-HNSC · largest of 2 cohorts | — | — | Head and Neck Squamous Cell Carcinoma | 2 | Observed | gdc | graph → |
| ← altered in cohorts of | ATAD2 368 / 528 cases (70 %) · ssm · TCGA-HNSC | — | — | Head and Neck Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ATP11B 368 / 528 cases (70 %) · ssm · TCGA-HNSC · largest of 2 cohorts | — | — | Head and Neck Squamous Cell Carcinoma | 2 | Observed | gdc | graph → |
| ← altered in cohorts of | FAM91A1 368 / 528 cases (70 %) · ssm · TCGA-HNSC | — | — | Head and Neck Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | FBXO45 368 / 528 cases (70 %) · ssm · TCGA-HNSC | — | — | Head and Neck Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | FYTTD1 368 / 528 cases (70 %) · ssm · TCGA-HNSC | — | — | Head and Neck Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | KLHL38 368 / 528 cases (70 %) · ssm · TCGA-HNSC | — | — | Head and Neck Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | LMLN 368 / 528 cases (70 %) · ssm · TCGA-HNSC | — | — | Head and Neck Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | LRRIQ4 368 / 528 cases (70 %) · ssm · TCGA-HNSC · largest of 2 cohorts | — | — | Head and Neck Squamous Cell Carcinoma | 2 | Observed | gdc | graph → |
| ← altered in cohorts of | MCF2L2 368 / 528 cases (70 %) · ssm · TCGA-HNSC · largest of 2 cohorts | — | — | Head and Neck Squamous Cell Carcinoma | 2 | Observed | gdc | graph → |
| ← altered in cohorts of | MECOM 368 / 528 cases (70 %) · ssm · TCGA-HNSC · largest of 2 cohorts | — | — | Head and Neck Squamous Cell Carcinoma | 2 | Observed | gdc | graph → |
| ← altered in cohorts of | MTBP 368 / 528 cases (70 %) · ssm · TCGA-HNSC | — | — | Head and Neck Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | NCBP2 368 / 528 cases (70 %) · ssm · TCGA-HNSC | — | — | Head and Neck Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | NCEH1 368 / 528 cases (70 %) · ssm · TCGA-HNSC · largest of 2 cohorts | — | — | Head and Neck Squamous Cell Carcinoma | 2 | Observed | gdc | graph → |
| ← altered in cohorts of | POU5F1B 368 / 528 cases (70 %) · ssm · TCGA-HNSC | — | — | Head and Neck Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | RNF139 368 / 528 cases (70 %) · ssm · TCGA-HNSC | — | — | Head and Neck Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | RPL35A 368 / 528 cases (70 %) · ssm · TCGA-HNSC | — | — | Head and Neck Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SLC51A 368 / 528 cases (70 %) · ssm · TCGA-HNSC | — | — | Head and Neck Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SLITRK3 368 / 528 cases (70 %) · ssm · TCGA-HNSC · largest of 5 cohorts | — | — | Head and Neck Squamous Cell Carcinoma | 5 | Observed | gdc | graph → |
| ← altered in cohorts of | SST 368 / 528 cases (70 %) · ssm · TCGA-HNSC | — | — | Head and Neck Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ST6GAL1 368 / 528 cases (70 %) · ssm · TCGA-HNSC | — | — | Head and Neck Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | TMEM212 368 / 528 cases (70 %) · ssm · TCGA-HNSC · largest of 2 cohorts | — | — | Head and Neck Squamous Cell Carcinoma | 2 | Observed | gdc | graph → |
| ← altered in cohorts of | TTC14 368 / 528 cases (70 %) · ssm · TCGA-HNSC · largest of 2 cohorts | — | — | Head and Neck Squamous Cell Carcinoma | 2 | Observed | gdc | graph → |
| ← altered in cohorts of | XXYLT1 368 / 528 cases (70 %) · ssm · TCGA-HNSC | — | — | Head and Neck Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ZDHHC19 368 / 528 cases (70 %) · ssm · TCGA-HNSC | — | — | Head and Neck Squamous Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SKIL 367 / 528 cases (70 %) · ssm · TCGA-HNSC · largest of 2 cohorts | — | — | Head and Neck Squamous Cell Carcinoma | 2 | Observed | gdc | graph → |
| ← altered in cohorts of | CFH 24 / 39 cases (62 %) · ssm · cscc_hgsc_bcm_2014 | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | COL6A5 24 / 39 cases (62 %) · ssm · cscc_hgsc_bcm_2014 · largest of 2 cohorts | — | — | Skin Squamous Cell Carcinoma | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ZNF469 23 / 39 cases (59 %) · ssm · cscc_hgsc_bcm_2014 · largest of 2 cohorts | — | — | Skin Squamous Cell Carcinoma | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | DGKB 22 / 39 cases (56 %) · ssm · cscc_hgsc_bcm_2014 | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | DNAH17 22 / 39 cases (56 %) · ssm · cscc_hgsc_bcm_2014 | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | SCN9A 22 / 39 cases (56 %) · ssm · cscc_hgsc_bcm_2014 | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | SLIT2 22 / 39 cases (56 %) · ssm · cscc_hgsc_bcm_2014 | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | FPGT-TNNI3K 21 / 39 cases (54 %) · ssm · cscc_hgsc_bcm_2014 | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | CNTN5 20 / 39 cases (51 %) · ssm · cscc_hgsc_bcm_2014 | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | TTN 211 / 515 cases (41 %) · ssm · hnsc_tcga_pan_can_atlas_2018 · largest of 19 cohorts | — | — | Head and Neck Squamous Cell Carcinoma | 19 | Observed | cbioportal | graph → |
| ← altered in cohorts of | NOTCH2 30 / 83 cases (36 %) · ssm · cscc_ucsf_2021 · largest of 2 cohorts | — | — | Skin Squamous Cell Carcinoma | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | COL24A1 29 / 83 cases (35 %) · ssm · cscc_ucsf_2021 | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | VWF 26 / 83 cases (31 %) · ssm · cscc_ucsf_2021 · largest of 2 cohorts | — | — | Skin Squamous Cell Carcinoma | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | FBN1 25 / 83 cases (30 %) · ssm · cscc_ucsf_2021 | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | SALL1 25 / 83 cases (30 %) · ssm · cscc_ucsf_2021 | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ADAM6 53 / 178 cases (30 %) · ssm · lusc_tcga | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | PLCE1 24 / 83 cases (29 %) · ssm · cscc_ucsf_2021 | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ARID2 23 / 83 cases (28 %) · ssm · cscc_ucsf_2021 | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | MYO15A 23 / 83 cases (28 %) · ssm · cscc_ucsf_2021 | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | BSN 22 / 83 cases (27 %) · ssm · cscc_ucsf_2021 | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | DMXL2 22 / 83 cases (27 %) · ssm · cscc_ucsf_2021 | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | PLCB4 22 / 83 cases (27 %) · ssm · cscc_ucsf_2021 | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | SLX4 22 / 83 cases (27 %) · ssm · cscc_ucsf_2021 | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ABCC9 21 / 83 cases (25 %) · ssm · cscc_ucsf_2021 | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | AKAP12 21 / 83 cases (25 %) · ssm · cscc_ucsf_2021 | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |